This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Antibiotics


  • Antibiotic Resistance Markers in Genetically Modified Plants Not a Risk to Human Health
    Antibiotic-resistance markers in genetically modified (GM) plants do not pose a substantial risk to human health, concludes a review article published in the October issue of The Lancet Infectious Diseases. Antibiotic resistance marker genes are used as a tool to recognize ...More
    September 27, 2005 Posted in News
  • Scientists Design Method to Fight Implant Infections
    Infections associated with inserting a medical device can be devastating, painful, and cause prolonged disability, costing tens of thousands of dollars. Now, researchers at Jefferson Medical College have found a way to create a permanent chemical bond between antibiotics ...More
    September 25, 2005 Posted in News
  • New Treatment Option for Childhood Cholera
    Researchers in Bangladesh have found that severe cholera in children can be treated effectively with a single dose of the antibiotic ciprofloxacin, according to a study published online by The Lancet. Cholera is a major global health problem particularly in children in ...More
    September 14, 2005 Posted in News
  • Reducing Antibiotic Use Lowers Rates of Drug-Resistant Bacteria
    Fewer antibiotic prescriptions lead to fewer superbugs. That's the take-home message behind a new study in the Oct. 15, 2005 issue of Clinical Infectious Diseases, now available online. The study found that reducing antibiotic use for pediatric respiratory tract infections ...More
    September 1, 2005 Posted in News
  • Unusual Antibiotics Show Promise Against Deadly Superbugs
    An unusual type of antibiotic being developed by chemists at Notre Dame University shows promise in defeating deadly superbugs -- highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day ...More
    August 29, 2005 Posted in News
  • Overcoming Drug Resistance
    Researchers at the University of Alabama at Birmingham (UAB) and Ohio State University have taken a major step in the battle against drug-resistant bacteria. New findings published in the journal Cell show for the first time a mechanism of how rifamycins, a family of ...More
    August 22, 2005 Posted in News
  • FDA Announces Final Decision About Antimicrobial Drug Used to Treat Bacterial Infections in Poultry
    Food and Drug Administration (FDA) Commissioner Lester Crawford announces the agency's final decision to no longer allow distribution or use of the antimicrobial drug enrofloxacin for the purpose of treating bacterial infections in poultry. This ruling does not affect other ...More
    July 29, 2005 Posted in News
  • Quality Measures Need to be Field-Tested, Researchers Find
    ALEXANDRIA, Va. -- A group of researchers has developed a set of "quality indicators" to measure the quality of antibiotic use in hospitalized patients with lower respiratory tract infections (LRTIs) by combining scientific evidence with expert opinion, according to an ...More
    July 26, 2005 Posted in News
  • Hospira Ships First Orders of Ceftriaxone Injection
    LAKE FOREST, Ill. -- Hospira, Inc. announced today that it has shipped the first customer orders of the company's generic ceftriaxone for injection, USP. The medication is the generic version of Roche Pharmaceuticals' Rocephin, the world's leading injectable antibiotic, ...More
    July 20, 2005 Posted in News
  • Research Shows Topical Silver as an Effective Defense Against Growing MRSA Threat
    PORTLAND, Ore. -- AcryMed Inc., a medical device company specializing in wound care and infection control technology, today released research findings that show silver to be effective in combating methicillin-resistant Staphylococcus aureus (MRSA) topically, a potentially ...More
    July 12, 2005 Posted in News